American Healthcare Reit, Inc. AHR
We take great care to ensure that the data presented and summarized in this overview for American Healthcare REIT, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in AHR
Top Purchases
Top Sells
About AHR
Insider Transactions at AHR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2025
|
Stefan K.L. Oh Chief Investment Officer |
SELL
Open market or private sale
|
Indirect |
3,860
-100.0%
|
$138,960
$36.1 P/Share
|
Jun 25
2025
|
Marvin R O'Quinn Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,042
+14.41%
|
-
|
Jun 25
2025
|
Mathieu B. Streiff Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,042
+8.59%
|
-
|
Jun 25
2025
|
Jeffrey T Hanson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,042
+6.78%
|
-
|
Jun 25
2025
|
Scott A Estes Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,042
+13.87%
|
-
|
Jun 25
2025
|
Brian J. Flornes Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,042
+9.09%
|
-
|
Jun 25
2025
|
Dianne Hurley Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,042
+8.82%
|
-
|
Jun 25
2025
|
Valerie Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,042
+14.41%
|
-
|
Jun 25
2025
|
Wilbur H Smith Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,042
+8.58%
|
-
|
Apr 03
2025
|
Stefan K.L. Oh Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,618
-1.66%
|
$48,540
$30.79 P/Share
|
Apr 03
2025
|
Stefan K.L. Oh Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,185
+3.17%
|
-
|
Apr 03
2025
|
Mark E. Foster EVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,517
-2.39%
|
$45,510
$30.79 P/Share
|
Apr 03
2025
|
Mark E. Foster EVP, GC & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,986
+4.5%
|
-
|
Apr 03
2025
|
Danny Prosky CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,924
+4.63%
|
-
|
Apr 03
2025
|
Brian Peay Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,437
-1.91%
|
$103,110
$30.79 P/Share
|
Apr 03
2025
|
Brian Peay Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,768
+3.62%
|
-
|
Apr 03
2025
|
Gabriel M Willhite Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,437
-2.28%
|
$103,110
$30.79 P/Share
|
Apr 03
2025
|
Gabriel M Willhite Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,768
+4.29%
|
-
|
Mar 25
2025
|
Brian Peay Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,971
-3.87%
|
$209,130
$30.45 P/Share
|
Mar 25
2025
|
Brian Peay Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,727
+7.08%
|
-
|
Last 12 Months Summary
Buy / Acquisition
152K
Shares
From
13
Insiders
Grant, award, or other acquisition | 24.3K shares |
---|---|
Exercise of conversion of derivative security | 128K shares |
Sell / Disposition
73.3K
Shares
From
5
Insiders
Payment of exercise price or tax liability | 69.4K shares |
---|---|
Open market or private sale | 3.86K shares |